Rallybio Statistics

Total Valuation

Rallybio has a market cap or net worth of $84.77 million. The enterprise value is $38.13 million.

Market Cap	84.77M
Enterprise Value	38.13M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, before market open.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Rallybio has 5.30 million shares outstanding. The number of shares has increased by 1.50% in one year.

Current Share Class	5.30M
Shares Outstanding	5.30M
Shares Change (YoY)	+1.50%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	18.87%
Owned by Institutions (%)	33.66%
Float	376,052

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	98.80
Forward PS	n/a
PB Ratio	1.68
P/TBV Ratio	1.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	44.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.92, with a Debt / Equity ratio of 0.00.

Current Ratio	12.92
Quick Ratio	11.30
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.98% and return on invested capital (ROIC) is -35.51%.

Return on Equity (ROE)	-14.98%
Return on Assets (ROA)	-33.04%
Return on Invested Capital (ROIC)	-35.51%
Return on Capital Employed (ROCE)	-59.05%
Weighted Average Cost of Capital (WACC)	-0.58%
Revenue Per Employee	$61,286
Profits Per Employee	-$558,357
Employee Count	14
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +470.61% in the last 52 weeks. The beta is -0.88, so Rallybio's price volatility has been lower than the market average.

Beta (5Y)	-0.88
52-Week Price Change	+470.61%
50-Day Moving Average	13.66
200-Day Moving Average	7.91
Relative Strength Index (RSI)	62.69
Average Volume (20 Days)	75,122

Short Selling Information

The latest short interest is 586,906, so 11.08% of the outstanding shares have been sold short.

Short Interest	586,906
Short Previous Month	578,792
Short % of Shares Out	11.08%
Short % of Float	n/a
Short Ratio (days to cover)	1.00

Income Statement

In the last 12 months, Rallybio had revenue of $858,000 and -$7.82 million in losses. Loss per share was -$1.38.

Revenue	858,000
Gross Profit	-14.68M
Operating Income	-29.72M
Pretax Income	-7.82M
Net Income	-7.82M
EBITDA	-29.66M
EBIT	-29.72M
Loss Per Share	-$1.38

Full Income Statement

Balance Sheet

The company has $46.80 million in cash and $154,000 in debt, giving a net cash position of $46.64 million or $8.80 per share.

Cash & Cash Equivalents	46.80M
Total Debt	154,000
Net Cash	46.64M
Net Cash Per Share	$8.80
Equity (Book Value)	50.28M
Book Value Per Share	9.50
Working Capital	49.35M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-27.59M
Capital Expenditures	n/a
Depreciation & Amortization	67,000
Net Borrowing	n/a
Free Cash Flow	-27.59M
FCF Per Share	-$5.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,464.27%
Pretax Margin	-911.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rallybio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.50%
Shareholder Yield	-1.50%
Earnings Yield	-9.22%
FCF Yield	-32.54%

Analyst Forecast

The average price target for Rallybio is $8.00, which is -50.00% lower than the current price. The consensus rating is "Hold".

Price Target	$8.00
Price Target Difference	-50.00%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on February 6, 2026. It was a reverse split with a ratio of 1:8.

Last Split Date	Feb 6, 2026
Split Type	Reverse
Split Ratio	1:8

Scores

Rallybio has an Altman Z-Score of -5.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.14
Piotroski F-Score	2